Skip to content
Dosage GuideResearch Reference

Ghrelin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Ghrelin. All information is for educational purposes only.

Quick Answer

Ghrelin is primarily used in research settings. Dosage depends heavily on the specific study goals and route of administration (IV, subcutaneous). In human studies, doses range from micrograms to low milligrams, typically administered once or twice daily. Individual response varies considerably. No standardized clinical dosing guidelines exist.

→ Ghrelin Benefits→ Ghrelin Side Effects→ Full Ghrelin Profile
Table of Contents

Standard Dosage Range

Research dosing range: Variable; research-dependent (mcg to low mg range)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Appetite Stimulation (Research)

1-10 mcg/kgSingle dose or 1-2× daily
Duration

Acute administration

Used to evaluate appetite response. Often administered intravenously in research settings. Subcutaneous administration can also be used but may have different absorption characteristics.

Growth Hormone Stimulation (Research)

0.1-1 mcg/kgSingle dose or pulsatile administration
Duration

Acute administration

Used to assess GH secretory capacity. IV administration is common for controlled research protocols.

Cachexia / Muscle Wasting (Clinical Trials)

0.5-2 mg1-3× daily
Duration

Weeks to months (clinical trials)

Typically in the form of ghrelin mimetics (e.g., anamorelin) administered orally. Aim is to improve lean body mass and appetite.

Gastroparesis (Research)

Variable (mcg range)Single dose or multiple daily doses
Duration

Acute or short-term studies

Used to assess effects on gastric emptying. Route of administration varies (IV, subcutaneous).

Timing & Frequency

For appetite stimulation, ghrelin or mimetics are often administered before meals. For GH stimulation studies, timing is controlled to assess pulsatile GH release. The short half-life necessitates frequent administration for sustained effects.

Cycle Guidance

Due to the lack of long-term safety data and the potential for tachyphylaxis (reduced response with repeated use), cycling may be considered in research settings. However, the primary limitation is the research setting itself rather than inherent properties of Ghrelin. Monitor for changes in appetite, GH levels, and other relevant markers.

Reconstitution Reference

Quick reference for reconstituting Ghrelin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeVariable; typically 1-5 mg per vial in research settings
BAC Water VolumeFollow manufacturer instructions; typically bacteriostatic water is used
Concentration & DrawConcentration depends on the vial size and water volume used. Calculate to achieve desired dosage per injection volume.
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable for a limited time (days to weeks) refrigerated. Lyophilized powder stable for months to years per manufacturer.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the best time to take ghrelin?
Ghrelin's timing depends on the research objective. For appetite stimulation, it's often administered before meals. For GH studies, it's timed to assess pulsatile release. Given its short half-life, frequent dosing might be needed for sustained effects.
Is ghrelin safe?
Ghrelin and its mimetics are under investigation, with safety profiles varying. Potential side effects include increased appetite, changes in GH levels, and potential metabolic effects. Consult a healthcare professional or research protocol for specifics.

Last updated: 2026-02-19